Risk and severity of SARS-CoV-2 infection in breast cancer patients undergoing a structured infection screening program at the University and Hospital Trust of Verona
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:33 |
|---|---|
| Enthalten in: |
Annals of oncology : official journal of the European Society for Medical Oncology - 33(2022), 6 vom: 01. Juni, Seite 661-663 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zanelli, S [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 03.06.2022 Date Revised 07.07.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.annonc.2022.02.227 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM338071466 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM338071466 | ||
| 003 | DE-627 | ||
| 005 | 20231225235837.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.annonc.2022.02.227 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1126.xml |
| 035 | |a (DE-627)NLM338071466 | ||
| 035 | |a (NLM)35276335 | ||
| 035 | |a (PII)S0923-7534(22)00363-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zanelli, S |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Risk and severity of SARS-CoV-2 infection in breast cancer patients undergoing a structured infection screening program at the University and Hospital Trust of Verona |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.06.2022 | ||
| 500 | |a Date Revised 07.07.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 700 | 1 | |a Fiorio, E |e verfasserin |4 aut | |
| 700 | 1 | |a Zampiva, I |e verfasserin |4 aut | |
| 700 | 1 | |a Zacchi, F |e verfasserin |4 aut | |
| 700 | 1 | |a Borghesani, G |e verfasserin |4 aut | |
| 700 | 1 | |a Giontella, E |e verfasserin |4 aut | |
| 700 | 1 | |a Parolin, V |e verfasserin |4 aut | |
| 700 | 1 | |a Biondani, P |e verfasserin |4 aut | |
| 700 | 1 | |a Zuliani, S |e verfasserin |4 aut | |
| 700 | 1 | |a Dieci, M V |e verfasserin |4 aut | |
| 700 | 1 | |a Mioranza, E |e verfasserin |4 aut | |
| 700 | 1 | |a Zorzi, M |e verfasserin |4 aut | |
| 700 | 1 | |a Conti, M |e verfasserin |4 aut | |
| 700 | 1 | |a Gibellini, D |e verfasserin |4 aut | |
| 700 | 1 | |a Verlato, G |e verfasserin |4 aut | |
| 700 | 1 | |a Milella, M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of oncology : official journal of the European Society for Medical Oncology |d 1990 |g 33(2022), 6 vom: 01. Juni, Seite 661-663 |w (DE-627)NLM012606308 |x 1569-8041 |7 nnns |
| 773 | 1 | 8 | |g volume:33 |g year:2022 |g number:6 |g day:01 |g month:06 |g pages:661-663 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.annonc.2022.02.227 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 33 |j 2022 |e 6 |b 01 |c 06 |h 661-663 | ||